Characterization of the contractile and relaxant action of the endothelin-1 precursor, big endothelin-1, in the isolated rat basilar artery

Peptides

Volumn 21, Issue 1, 2000, Pages 91-99

  Schilling, L ^a   Vatter, H ^a   Mursch, K ^b   Ehrenreich, H ^c   Schmiedek, P ^a  

^a Department of Neurosurgery   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Big endothelin 1; Endothelial function; Endothelin converting enzyme; Endothelin 1; In vitro; Rat basilar artery

Indexed keywords

BIG ENDOTHELIN 1; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; PHOSPHORAMIDON; PROSTAGLANDIN;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BASILAR ARTERY; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ANIMALS; ASPARTIC ENDOPEPTIDASES; BASILAR ARTERY; ENDOTHELIN-1; ENDOTHELINS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GLYCOPEPTIDES; MALE; METALLOENDOPEPTIDASES; MICROSCOPY, ELECTRON; PEPTIDES, CYCLIC; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; VASOCONSTRICTION; VASODILATION;

ANIMALIA;

EID: 0034001055     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00179-5     Document Type: Article

References (48)

1. Armstead W.M. Role of endothelin in pial artery vasoconstriction and altered responses to vasopressin after brain injury. J Neurosurg. 85:1996;901-907.
2. Auguet M., Delaflotte S., Chabrier P.E., Braquet P. The vasoconstrictor action of big endothelin-1 is phosphoramidon-sensitive in rabbit saphenous artery, but not in saphenous vein. Eur J Pharmacol. 224:1992;101-102.
3. Bax W.A., Saxena P.R. The current endothelin receptor classification time for reconsideration? Trends Pharmacol Sci. 15:1994;379-386.
4. Caner H.H., Kwan A.-L., Arthur A., Jeng A.Y., Lappe R.W., Kassell N.F., Lee K.S. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage. J Neurosurg. 85:1996;917-922.
5. Chen L., McNeill R., Wilson T.W., Gopalakrishnan V. Differential effects of phosphoramidon on contractile responses to angiotensin II in rat blood vessels. Brit J Pharmacol. 114:1995;1599-1604.
6. Clozel M., Watanabe H. BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci. 52:1993;825-834.
7. Corder R., Vane J.R. Radioimmunoassay evidence that the pressor effect of big endothelin-1 is due to local conversion to endothelin-1. Biochem Pharmacol. 49:1995;375-380.
8. Douglas S.A., Hiley C.R. Endothelium-dependent mesenteric vasorelaxant effects and systemic actions of endothelin (16-21) and other endothelin-related peptides in the rat. Brit J Pharmacol. 104:1991;311-320.
9. Ehrenreich H., Kehrl J.H., Anderson R.W., Rieckmann P., Vitkovic L., Coligan J.E., Fauci A.S. A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes. Brain Res. 538:1991;54-58.
10. Ehrenreich H., Lange M., Near K.A., Anneser F., Schoeller L.A.C., Schmid R., Winkler P.A., Kehrl J.H., Schmiedek P., Goebel F.-D. Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhage. Res Exp Med. 192:1992;257-268.
11. Ehrenreich H., Löffler B.-M., Hasselblatt M., et al. Endothelin converting enzyme activity in primary rat astrocytes is modulated by endothelin B receptors. Biochem Biophys Res Commun. 261:1999;49-155.
12. Ehrenreich H., Schilling L. New developments in understanding cerebral vasoregulation and vasospasm. The endothelin-nitric oxide network. Cleveland Clin J Med. 62:1995;105-116.
13. Emoto N., Yanagisawa M. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidone-sensitive metalloprotease with acidic pH optimum. J Biol Chem. 270:1995;15262-15268.
14. Feger G.I., Schilling L., Ehrenreich H., Wahl M. Endothelin induced contraction and relaxation of rat isolated basilar artery effect of BQ-123 . J Cereb Blood Flow Metab. 14:1994;845-852.
15. B receptor activation. Res Exp Med. 196:1997;327-337.
16. A receptor. Life Sci. 50:1992;247-255.
17. Ikegawa R., Matsumura Y., Tsukahara Y., Takaoka M., Morimoto S. Phosphoramidon inhibits the generation of endothelin-1 from exogenously applied big endothelin-1 in cultured vascular endothelial cells and smooth muscle cells. FEBS Lett. 293:1991;45-48.
18. Ishikawa K., Ihara M., Noguchi K., et al. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA. 91:1994;4892-4896.
19. A receptor mRNA expression in a canine subarachnoid hemorrhage model . J Neurosurg. 81:1994;759-764.
20. Kashiwabara T., Inagaki Y., Ohta H., et al. Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo. FEBS Lett. 247:1989;73-76.
21. Kitazono T., Heistad D.D., Faraci F.M. Dilatation of basilar artery in response to activation of endothelin B receptors during chronic hypertension. Stroke. 25:1994;65.
22. Kitazono T., Heistad D.D., Faraci F.M. Dilatation of the basilar artery in response to selective activation of endothelin B receptors in vivo. J Pharmacol Exp Ther. 273:1995;1-6.
23. Koedel U., Gorriz C., Lorenzl S., Pfister H.W. Increased endothelin levels in cerebrospinal fluid samples from adults with bacterial meningitis. Clin Infect Dis. 25:1997;329-330.
24. Kraus G.E., Bucholz R.D., Yoon K.-W., Knuepfer M.M., Smith K.R. Cerebrospinal fluid endothelin-1 and endothelin-3 levels in normal and neurosurgical patients a clinical study and literature review . Surg Neurol. 35:1991;20-29.
25. Kwan A.-L., Bavbek M., Jeng A.Y., et al. Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage. J Neurosurg. 87:1997;281-286.
26. Lampl Y., Fleminger G., Gilad R., Galron R., Sarova-Pinhas I., Sokolovsky M. Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke. 28:1997;1951-1955.
27. Lee M.-E., de la Monte S.M., Ng S.-C., Bloch K.D., Quertermous T. Expression of the potent vasoconstrictor endothelin in the human central nervous system. J Clin Invest. 86:1990;141-147.
28. Matsumura Y., Ikegawa R., Suzuki Y., et al. Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs the relationship to endothelin-1 levels in the cerebrospinal fluid . Life Sci. 49:1991;841-848.
29. Parnot C., LeMoullec J.-M., Cousin M.-A., Guédin D., Corvol P., Pinet F. A live-cell assay for studying extracellular and intracellular endothelin-converting enzyme activity. Hypertension. 30:1997;837-844.
30. Petersson J., Hanson G.C., Lindberg B.F., Högestätt E.D. Contractile effect of big endothelin-1 and its conversion to endothelin-1 in rabbit cerebral arteries. Naunyn-Schmiedeberg's Arch Pharmacol. 354:1996;656-661.
31. Roux S., Löffler B.-M., Gray G.A., Sprecher U., Clozel M., Clozel J.-P. The role of endothelin in experimental cerebral vasospasm. Neurosurgery. 37:1995;78-86.
32. Rubanyi G.M., Polokoff M.A. Endothelins molecular biology, biochemistry, pharmacology, physiology, and pathophysiology . Pharmacol Rev. 46:1994;325-415.
33. B-type endothelin receptor. J Cereb Blood Flow Metab. 15:1995;699-705.
34. Schilling L., Kanzler C., Schmiedek P., Ehrenreich H. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery. Brit J Pharmacol. 125:1998;1164-1171.
35. Schilling L., Vatter H., Schmiedek P. Functional evidence for endothelin converting enzyme (ECE) activity in the smooth muscle cells of the rat basilar artery. J Cereb Blood Flow Metab. 17:(suppl. 1):1997;S289.
36. Seifert V., Löffler B.-M., Zimmerman M., Roux S., Stolke D. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage correlation with cerebral vasospasm, delayed ischemic neurological deficits and volume of hematoma . J Neurosurg. 82:1995;55-62.
37. Spatz M., Stanimirovic D., Strasser A., McCarron R. Nitro-L-arginine augments the endothelin-1 content of cerebrospinal fluid induced by cerebral ischemia. Brain Res. 1995;99-102.
38. A receptors. Brain Res. 726:1996;242-246.
39. Suzuki R., Masaoka H., Hirata Y., Marumo F., Isotani E., Hirakawa K. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 77:1992;96-100.
40. Takahashi M., Fukuda K., Shimada K., et al. Localization of rat endothelin-converting enzyme to vascular endothelial cells and some secretory cells. Biochem. J. 311:1995;657-665.
41. Turner A.J., Barnes K., Schweizer A., Valdenaire O. Isoforms of endothelin-converting enzyme why and where? Trends Pharmacol Sci. 19:1998;483-486.
42. Turner A.J., Murphy L.J. Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol. 51:1996;91-102.
43. Vatter H, Schilling L, Schmiedek P. Contractile effect of big endothelin-1 in isolated rat basilar artery: effect of putative endothelin-converting enzyme (ECE) inhibitors. Zentralbl Neurochir Suppl. 1998:139.
44. Vatter H., Schilling L., Schmiedek P., Ehrenreich H. Evidence for functional endothelin-converting enzyme activity in isolated rat basilar artery effects of inhibitors . J Cardiovasc Pharmacol. 31:(suppl 1):1998;S64-S67.
45. Xu D., Emoto N., Giaid A., Slaughter C., Kaw S., deWit D., Yanagisawa M. ECE-1 a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1 . Cell. 78:1994;473-485.
46. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
47. Yu J.C.M., Davenport A.P. Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells. Brit J Pharmacol. 114:1995;551-557.
48. Zuccarello M., Soattin G.B., Lewis A.I., Breu V., Hallak H., Rapoport R.M. Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists. J Neurosurg. 84:1996;503-507.